An investigative technique to distinguish  between the gastrojejunostomy and the  hepaticojejunostomy as the cause of cholangitis  following pancreaticoduodenectomy.
Lordan
Jeffrey T
JT
Royal Surrey County Hospital, Guildford, Surrey, UK. dr_lordan@yahoo.co.uk
Karanjia
Nariman D
ND
Hussain
Fuad F
FF
Bowyer
Richard C
RC
D001464:Barium / Q000008:administration & dosage; D002761:Cholangitis / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control; D003287:Contrast Media / Q000008:administration & dosage; D003974:Diatrizoate Meglumine / Q000008:administration & dosage; D004917:Erythromycin / Q000008:administration & dosage*; D015390:Gastric Bypass / Q000009:adverse effects*; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006801:Humans; D016577:Pancreaticoduodenectomy / Q000009:adverse effects*
D003287:Contrast Media; D005765:Gastrointestinal Agents; D001464:Barium; D003974:Diatrizoate Meglumine; D004917:Erythromycin